Department of Surgery, McMaster University, 237 Barton Street East, Room 604 North, Hamilton, ON L8L 2X2, Canada.
Breast. 2012 Jun;21(3):230-6. doi: 10.1016/j.breast.2011.12.013. Epub 2012 Jan 5.
The main priorities in the surgical treatment of patients with breast cancer are to achieve cure, local control and prevent recurrence. It is increasingly important to address quality of life and self-image with women undergoing surgical intervention for breast cancer. There is a lack of consensus as to the oncologic safety of immediate breast reconstruction (IBR). The purpose of this paper is to systematically review the literature and compare the frequency of recurrence in patients with and without IBR following mastectomy for breast cancer.
Two independent investigators searched PubMed, Embase, and the Cochrane database using predefined search terms. After application of inclusion and exclusion criteria, 10 articles remained. Each article was assessed for quality. Relevant data was collected including recurrence rates, cancer stage, type of mastectomy and reconstruction, adjuvant treatments, and duration of follow-up.
Inter-rater reliability was good at 74% (95% CI: 0, 93%). There was no evidence of study heterogeneity (p for Q-statistic=0.34 and I(2)=12%). The OR ratio for recurrence of breast cancer for mastectomy with IBR as compared to mastectomy alone was 0.98 (95% CI: 0.62, 1.54).
This meta-analysis demonstrated no evidence for increased frequency of local breast cancer recurrence with IBR compared with mastectomy alone.
乳腺癌患者外科治疗的主要重点是实现治愈、局部控制和预防复发。对于接受乳腺癌外科干预的女性,解决生活质量和自我形象问题变得越来越重要。即刻乳房重建(IBR)的肿瘤安全性尚未达成共识。本文旨在通过系统综述文献,比较乳腺癌乳房切除术后IBR 与非 IBR 患者的复发频率。
两位独立研究者使用预设的检索词在 PubMed、Embase 和 Cochrane 数据库中进行搜索。应用纳入和排除标准后,有 10 篇文章入选。对每篇文章进行质量评估。收集了包括复发率、癌症分期、乳房切除术和重建类型、辅助治疗以及随访时间等相关数据。
两位研究者间的一致性很好,为 74%(95%置信区间:0,93%)。没有研究异质性的证据(Q 统计量的 p 值为 0.34,I²为 12%)。与单纯乳房切除术相比,IBR 乳房切除术的乳腺癌复发的 OR 比值为 0.98(95%置信区间:0.62,1.54)。
本荟萃分析未发现 IBR 与单纯乳房切除术相比,乳腺癌局部复发频率增加的证据。